NCT07137455

Brief Summary

Background: Heart surgeons use electrocardiogram (ECG) machines to record electrical signals from the heart during procedures. Normal ECG machines connect only to the skin. Special ECG machines connect directly to the heart; they are a safer option during procedures. Researchers want to test a new ECG machine called the EDEN system. Objective: To test the EDEN system in people having heart procedures. The new system will be used along with an approved special ECG machine. Eligibility: People aged 21 years or older who need to have a heart procedure. These procedures can include (1) electrophysiology mapping or ablation; and (2) conduction system pacing. Design: Researchers will review participants' medical records. No extra tests are needed. Participants will have their heart procedure as planned. The EDEN system will be linked to the special ECG used during the procedure. An extra electrode may be placed on the participant's body. Electrodes are small stickers attached to wires that go to the machine. The EDEN system will record and analyze electrical signals already being measured. It will not interfere with participants' care. No medical decisions well be made based on its data. No follow-up visits are needed for this study....

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
6mo left

Started Apr 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 19, 2025

Completed
3 days until next milestone

First Posted

Study publicly available on registry

August 22, 2025

Completed
8 months until next milestone

Study Start

First participant enrolled

April 21, 2026

Expected
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2026

Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2026

Last Updated

April 16, 2026

Status Verified

March 25, 2026

Enrollment Period

6 months

First QC Date

August 19, 2025

Last Update Submit

April 15, 2026

Conditions

Keywords

intracardiac electrogramradial depth

Outcome Measures

Primary Outcomes (1)

  • Classifier accuracy

    The primary endpoint is classification accuracy of EDEN electrograms automated classifications compared with operator-determined classifications of radial depth according to a five-element ordinal scale (cameral, subendocardial, midmyocardial, subepicardial, pericardial). Agreement will be assessed using standard metrics such as concordance.

    During intracardiac electrograms procedure

Study Arms (1)

EDEN Intracardiac Electrogram Recording and Classifying System

EXPERIMENTAL

EDEN will be used to record and classify intracardiac electrograms obtained in the practice of medicine.

Device: EDEN Intracardiac Electrogram Recording and Classifying System

Interventions

EDEN will be used to record and classify intracardiac electrograms obtained in the practice of medicine.

EDEN Intracardiac Electrogram Recording and Classifying System

Eligibility Criteria

Age21 Years - 100 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age \>= 21 years
  • Undergoing a medically-necessary invasive cardiac electrophysiology mapping and/or ablation procedure for ventricular arrhythmia, or conduction system pacing procedure

You may not qualify if:

  • Does not consent to participate, or unable to consent to participate
  • Hemodynamic instability or emergency procedure

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Emory University Hospital

Atlanta, Georgia, 30322, United States

Location

Study Officials

  • Robert J Lederman, M.D.

    National Heart, Lung, and Blood Institute (NHLBI)

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
NIH
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 19, 2025

First Posted

August 22, 2025

Study Start (Estimated)

April 21, 2026

Primary Completion (Estimated)

November 1, 2026

Study Completion (Estimated)

November 1, 2026

Last Updated

April 16, 2026

Record last verified: 2026-03-25

Data Sharing

IPD Sharing
Will share

IPD that underline results in a publication will be shared. Medical images will not be shared because of intrinsic inability to protect confidentiality with reasonable effort.

Shared Documents
STUDY PROTOCOL, ICF
Time Frame
Data will be made available by the end of the project or protocol or at the time of associated publication.
Access Criteria
BioData Catalyst is supported by NHLBI and access to data is controlled by the NHLBI Data Access Committee (DAC) utilizing the database of Genotypes and Phenotypes (dbGaP) permissions infrastructure. In order to access controlled-access data in BioData Catalyst, an investigator must have an approved Data Access Request (DAR) in dbGaP.

Locations